Achievement of Lipid Targets with the Combination of Rosuvastatin and Fenofibric Acid in Patients with Type 2 Diabetes Mellitus

Por Rosenson, Robert S., Carlson, Dawn M., Kelly, Maureen T., Setze, Carolyn M., Hirshberg, Boaz, Stolzenbach, James C., Williams, Laura A.
Publicado em 2010

Long-Term Efficacy of Adding Fenofibric Acid to Moderate-Dose Statin Therapy in Patients with Persistent Elevated Triglycerides

Por Ballantyne, Christie M., Jones, Peter H., Kelly, Maureen T., Setze, Carolyn M., Lele, Aditya, Thakker, Kamlesh M., Stolzenbach, James C.
Publicado em 2011

The Effects of Fenofibric Acid Alone and With Statins on the Prevalence of Metabolic Syndrome and Its Diagnostic Components in Patients With Mixed Dyslipidemia

Por Bays, Harold E., Roth, Eli M., McKenney, James M., Kelly, Maureen T., Thakker, Kamlesh M., Setze, Carolyn M., Obermeyer, Katie, Sleep, Darryl J.
Publicado em 2010